OP21 ABX464 is safe and efficacious in a proof-of-concept...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

OP21 ABX464 is safe and efficacious in a proof-of-concept study in ulcerative colitis patients

Vermeire, S, Hébuterne, X, Napora, P, Wisniewska-Jarosinska, M, Kiss, G, Bourreille, A, Przemysław, Z, Nitcheu, J, Gineste, P, Steens, J-M, Ehrlich, H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.020
Date:
January, 2019
File:
PDF, 302 KB
2019
Conversion to is in progress
Conversion to is failed